Greytown Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.9M | Buy |
72,196
+218
| +0.3% | +$5.75K | 1.12% | 19 |
|
|
2024
Q1 | $2.19M | Sell |
71,978
-2,812
| -4% | -$85.4K | 1.23% | 16 |
|
|
2023
Q4 | $2.1M | Buy |
74,790
+189
| +0.3% | +$5.31K | 1.12% | 17 |
|
|
2023
Q3 | $2.02M | Buy |
74,601
+5,410
| +8% | +$147K | 1.12% | 17 |
|
|
2023
Q2 | $2.13M | Buy |
69,191
+593
| +0.9% | +$18.2K | 1.16% | 16 |
|
|
2023
Q1 | $2.47M | Buy |
68,598
+13,917
| +25% | +$501K | 1.28% | 17 |
|
|
2022
Q4 | $2.16M | Buy |
54,681
+4,208
| +8% | +$166K | 1.17% | 17 |
|
|
2022
Q3 | $2.03M | Sell |
50,473
-83,036
| -62% | -$3.34M | 1.23% | 17 |
|
|
2022
Q2 | $5.61M | Buy |
133,509
+2,366
| +2% | +$99.5K | 3.18% | 8 |
|
|
2022
Q1 | $5.11M | Buy |
131,143
+4,260
| +3% | +$166K | 2.47% | 11 |
|
|
2021
Q4 | $5.06M | Buy |
126,883
+20,562
| +19% | +$819K | 2.15% | 12 |
|
|
2021
Q3 | $3.84M | Buy |
+106,321
| New | +$3.84M | 1.71% | 11 |
|